股市必读：万孚生物（300482）12月22日董秘有最新回复

Core Viewpoint - The company, Wanfu Biotech, is actively tracking national fertility support policies and adapting its product offerings in the reproductive health sector to align with market demands and policy changes [2][4][5]. Group 1: Company Performance and Market Strategy - As of December 22, 2025, Wanfu Biotech's stock closed at 19.88 yuan, down 0.95%, with a turnover rate of 0.85% and a trading volume of 36,500 shares, amounting to 72.81 million yuan [1]. - The company has seen rapid growth in sales of its glycosylated hemoglobin testing products, driven by new public health policies that include free testing for seniors [3]. - Wanfu Biotech is focusing on expanding its product line in the reproductive health sector, including prenatal infectious disease monitoring and reproductive ability testing, to meet the increasing demand from fertility support policies [2][4][5]. Group 2: Product Development and R&D Investment - The company is committed to increasing R&D investment in its reproductive health segment, particularly in differentiated products like AI-assisted pregnancy tools and sperm quality testing [2][4]. - Wanfu Biotech is exploring collaborations with reproductive centers and maternal and child platforms to enhance market share and promote its products in response to fertility subsidy policies [2][4][5]. - The company is also evaluating the feasibility of developing high-end detection technologies, such as molecular imprinting sensors, in the cannabis testing sector [7]. Group 3: Regulatory and Policy Adaptation - Wanfu Biotech is closely monitoring the implementation of national fertility policies and adjusting its marketing and supply strategies accordingly [2][4][5]. - The company is working on optimizing product pricing and promotional strategies to align with insurance reimbursement scenarios, particularly in the reproductive health testing segment [6][9]. - The company has established a stable supply chain system to mitigate risks associated with raw material price fluctuations and ensure cost control [12].